Integrated Health Services

Integrated Health Services (IHS) is a biotechnology-focused healthcare provider dedicated to the clinical application of regenerative medicine and gene therapies aimed at extending human longevity. The company facilitates access to experimental treatments designed to combat biological aging and treat chronic conditions such as sarcopenia, cognitive decline, and metabolic disorders. IHS works in close collaboration with BioViva Science to implement genetic protocols, including telomerase reverse transcriptase (TERT) induction and myostatin inhibition via follistatin. By operating within international regulatory frameworks, IHS provides a platform for patients to receive cutting-edge therapies while collecting data to advance the field of regenerative medicine. The company's services include comprehensive medical screening, treatment administration, and long-term follow-up for individuals seeking to optimize their healthspan.